CF Industries Earnings Calls
| Release date | May 06, 2026 |
| EPS estimate | $2.63 |
| EPS actual | $2.89 |
| EPS Surprise | 9.89% |
| Revenue estimate | 1.839B |
| Revenue actual | 1.986B |
| Revenue Surprise | 8.01% |
| Release date | Feb 18, 2026 |
| EPS estimate | $2.43 |
| EPS actual | $2.99 |
| EPS Surprise | 23.05% |
| Revenue estimate | 1.783B |
| Revenue actual | 1.872B |
| Revenue Surprise | 4.99% |
| Release date | Nov 05, 2025 |
| EPS estimate | $2.16 |
| EPS actual | $2.19 |
| EPS Surprise | 1.39% |
| Revenue estimate | 1.668B |
| Revenue actual | 1.659B |
| Revenue Surprise | -0.543% |
| Release date | Aug 06, 2025 |
| EPS estimate | $2.50 |
| EPS actual | $2.37 |
| EPS Surprise | -5.20% |
| Revenue estimate | 1.804B |
| Revenue actual | 1.89B |
| Revenue Surprise | 4.78% |
Last 4 Quarters for CF Industries
Below you can see how CF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 06, 2025 |
| Price on release | $89.90 |
| EPS estimate | $2.50 |
| EPS actual | $2.37 |
| EPS surprise | -5.20% |
| Date | Price |
|---|---|
| Jul 31, 2025 | $92.83 |
| Aug 01, 2025 | $91.56 |
| Aug 04, 2025 | $93.65 |
| Aug 05, 2025 | $92.72 |
| Aug 06, 2025 | $89.90 |
| Aug 07, 2025 | $82.89 |
| Aug 08, 2025 | $80.91 |
| Aug 11, 2025 | $82.63 |
| Aug 12, 2025 | $82.90 |
| 4 days before | -3.16% |
| 4 days after | -7.79% |
| On release day | -7.80% |
| Change in period | -10.70% |
| Release date | Nov 05, 2025 |
| Price on release | $85.05 |
| EPS estimate | $2.16 |
| EPS actual | $2.19 |
| EPS surprise | 1.39% |
| Date | Price |
|---|---|
| Oct 30, 2025 | $82.81 |
| Oct 31, 2025 | $83.29 |
| Nov 03, 2025 | $84.41 |
| Nov 04, 2025 | $84.55 |
| Nov 05, 2025 | $85.05 |
| Nov 06, 2025 | $81.45 |
| Nov 07, 2025 | $82.03 |
| Nov 10, 2025 | $82.81 |
| Nov 11, 2025 | $83.68 |
| 4 days before | 2.70% |
| 4 days after | -1.61% |
| On release day | -4.23% |
| Change in period | 1.05% |
| Release date | Feb 18, 2026 |
| Price on release | $95.81 |
| EPS estimate | $2.43 |
| EPS actual | $2.99 |
| EPS surprise | 23.05% |
| Date | Price |
|---|---|
| Feb 11, 2026 | $96.93 |
| Feb 12, 2026 | $94.16 |
| Feb 13, 2026 | $94.66 |
| Feb 17, 2026 | $93.79 |
| Feb 18, 2026 | $95.81 |
| Feb 19, 2026 | $99.46 |
| Feb 20, 2026 | $97.18 |
| Feb 23, 2026 | $95.45 |
| Feb 24, 2026 | $96.11 |
| 4 days before | -1.16% |
| 4 days after | 0.313% |
| On release day | 3.81% |
| Change in period | -0.85% |
| Release date | May 06, 2026 |
| Price on release | $119.74 |
| EPS estimate | $2.63 |
| EPS actual | $2.89 |
| EPS surprise | 9.89% |
| Date | Price |
|---|---|
| Apr 30, 2026 | $124.20 |
| May 01, 2026 | $122.69 |
| May 04, 2026 | $125.89 |
| May 05, 2026 | $128.04 |
| May 06, 2026 | $119.74 |
| May 07, 2026 | $118.68 |
| May 08, 2026 | $115.00 |
| May 11, 2026 | $124.48 |
| May 12, 2026 | $130.39 |
| 4 days before | -3.59% |
| 4 days after | 8.89% |
| On release day | -0.89% |
| Change in period | 4.98% |
CF Industries Earnings Call Transcript Summary of Q1 2026
CF Industries reported strong 2026 results with adjusted EBITDA of $983 million and net earnings of ~$615 million ($3.98 per diluted share). The company ran ammonia capacity near 100%, delivered product to meet North American spring demand, and maintained excellent safety metrics. Management emphasized a materially tighter global nitrogen market driven by geopolitical disruptions (conflict with Iran, Strait of Hormuz closure, continued Russia-Ukraine impacts), export restrictions (China, Russia, Egypt), LNG feedstock constraints, and disrupted trade flows. These dynamics have increased a geopolitical risk premium, changed the industry risk-return profile, and strengthened mid-cycle pricing expectations for urea and related products into 2026–2027 and beyond. CF highlighted North America as a premium, low-cost/low-risk position due to its scale, distribution network, and decarbonization initiatives. The company reiterated disciplined capital allocation: consolidated CapEx of ~$1.3 billion for 2026 (CFH share ~$950 million, including Blue Point), ongoing share repurchases (about $150k shares/$15M repurchased in Q1; ~$1.7 billion remaining authorization), and high free-cash-flow conversion (trailing 12-month free cash flow ~ $1.65 billion). Construction of the Blue Point ammonia complex is expected to start after permits are received, with first unit targeted late 2029 and potential for future expansion evaluated prudently. Management expects elevated pricing and persistent tightness into 2027, with opportunities for additional high-return investments and continued shareholder returns.
Sign In
Buy CF